Renal denervation catheters are categorized into the following: radiofrequency (RF) catheters, ultrasound catheters, and micro-injection catheters.
Growth in the renal denervation market will be driven primarily by a need for a new intervention to treat resistant hypertension.
This technology has the potential to revolutionize the cardiac field, providing a minimally invasive solution where none currently exist.
The global market for renal denervation devices is dominated by Medtronic, St. Jude Medical, and Boston Scientific.
Other key players include Cordis, ReCor Medical, and Terumo
Competitive assessment: Currently marketed renal denervation products and evolving competitive landscape
In-depth analysis of unmet needs and adoption trends of different renal denervation devices
Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications
Pipeline analysis: Emerging products and technologies.
Annualized total renal denervation diagnostics market revenue by segment and market outlooks by country from 2012–2022.
Other key topics covered include strategic competitive assessment, market characterization, identification of unmet needs, market dynamics, and implications of the emerging technologies on the market.
Request Sample Pages